Published in Nutrition on September 01, 2013
Algorithm to improve accuracy of energy expended in a room calorimeter. Med Biol Eng Comput (2016) 0.75
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Medical sequencing at the extremes of human body mass. Am J Hum Genet (2007) 5.61
Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med (2005) 4.61
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest (2003) 4.42
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med (2009) 4.13
The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med (2005) 4.07
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med (2011) 3.79
The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr (2008) 3.27
Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr (2006) 2.73
Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med (2004) 2.56
Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS (2007) 2.52
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51
For the law, neuroscience changes nothing and everything. Philos Trans R Soc Lond B Biol Sci (2004) 2.46
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17
Sepsis: time to reconsider the concept. Crit Care Med (2008) 2.17
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med (2006) 2.04
A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock (2005) 1.97
Training with the compactEASIE biologic endoscopy simulator significantly improves hemostatic technical skill of gastroenterology fellows: a randomized controlled comparison with clinical endoscopy training alone. Gastrointest Endosc (2005) 1.96
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis (2005) 1.91
A systematic review of population screening for fragile X syndrome. Genet Med (2010) 1.87
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81
Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J Antimicrob Chemother (2006) 1.70
Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet (2002) 1.69
Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2011. Gastrointest Endosc (2011) 1.69
Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med (2008) 1.57
Extubation outcome following a spontaneous breathing trial with automatic tube compensation versus continuous positive airway pressure. Crit Care Med (2006) 1.53
Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens. Crit Care Med (2003) 1.51
Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr (2006) 1.50
Quality indicators for endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (2006) 1.46
Addressing the educational void during the antiretroviral therapy rollout. AIDS (2004) 1.45
HIV testing experiences among male and female inmates in Rhode Island. AIDS Read (2007) 1.45
Preemptive enteral nutrition enriched with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in severe multiple trauma: a prospective, randomized, double-blind study. Intensive Care Med (2015) 1.45
Comparison of metabolic monitors in critically ill, ventilated patients. Nutrition (2006) 1.44
To implement guidelines: the (bad) example of protein administration in the ICU. JPEN J Parenter Enteral Nutr (2013) 1.44
Laparoscopic sleeve gastrectomy--volume and pressure assessment. Obes Surg (2008) 1.44
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Gastrointest Endosc (2006) 1.42
Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol (2006) 1.42
Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother (2010) 1.42
Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis (2007) 1.36
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol (2005) 1.32
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol (2006) 1.30
"Opt-out" testing for HIV in Africa: a caution. Lancet (2004) 1.30
ERCP core curriculum. Gastrointest Endosc (2006) 1.30
Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. Crit Care (2013) 1.29
Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides. Ther Clin Risk Manag (2008) 1.27
Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med (2010) 1.26
The less they know, the better: abstinence-only HIV/AIDS programs in Uganda. Reprod Health Matters (2006) 1.25
Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection. J Immunol (2002) 1.25
The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol (2002) 1.24
Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry (2002) 1.21
Health benefits of legal services for criminalized populations: the case of people who use drugs, sex workers and sexual and gender minorities. J Law Med Ethics (2010) 1.18
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
Excellence in endoscopy: toward practical metrics. Gastrointest Endosc (2006) 1.15
How nutritional risk is assessed and managed in European hospitals: a survey of 21,007 patients findings from the 2007-2008 cross-sectional nutritionDay survey. Clin Nutr (2010) 1.15
Predictors of stress in mothers and fathers of children with fragile X syndrome. Res Dev Disabil (2005) 1.13
Human rights and HIV prevention, treatment, and care for people who inject drugs: key principles and research needs. J Acquir Immune Defic Syndr (2010) 1.12
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics. Intensive Care Med (2015) 1.12
Lives to save: PEPFAR, HIV, and injecting drug use in Africa. Lancet (2009) 1.11
Avoiding underfeeding in severely ill patients. Lancet (2013) 1.11
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains. Infect Immun (2011) 1.10
Readmission to the intensive care unit after "fast-track" cardiac surgery: risk factors and outcomes. Ann Thorac Surg (2003) 1.09
The Neo-Papilla: a new modification of porcine ex vivo simulators for ERCP training (with videos). Gastrointest Endosc (2006) 1.07
Quality indicators for esophagogastroduodenoscopy. Am J Gastroenterol (2006) 1.06
The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin Nutr (2010) 1.05
Changes in regional distribution of lung sounds as a function of positive end-expiratory pressure. Crit Care (2009) 1.04
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.04
Monetary benefits of preventing childhood lead poisoning with lead-safe window replacement. Environ Res (2007) 1.03
Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut (2006) 1.03
Guidelines for safety in the gastrointestinal endoscopy unit. Gastrointest Endosc (2014) 1.03
Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg (2004) 1.02
A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study. Genet Med (2008) 1.00
Efficacy and costs of a one-day hands-on EASIE endoscopy simulator train-the-trainer workshop. Gastrointest Endosc (2005) 1.00
HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol (2004) 0.98
Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time. BJU Int (2005) 0.97
Hypophosphatemia following open heart surgery: incidence and consequences. Eur J Cardiothorac Surg (2004) 0.96
Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome. Neurosci Biobehav Rev (2013) 0.95
Prediction of extubation outcome: a randomised, controlled trial with automatic tube compensation vs. pressure support ventilation. Crit Care (2009) 0.95
Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. Infect Immun (2002) 0.95
Quality indicators for endoscopic ultrasonography. Am J Gastroenterol (2006) 0.94
Quality indicators for endoscopic ultrasonography. Gastrointest Endosc (2006) 0.94
Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Control Hosp Epidemiol (2011) 0.92
Successful treatment of Bouveret syndrome using holmium: YAG laser lithotripsy. Am Surg (2005) 0.92
Quality indicators for EGD. Gastrointest Endosc (2014) 0.92
Quality indicators for ERCP. Gastrointest Endosc (2014) 0.92
Increasing access to HIV testing and counselling while respecting human rights. HIV AIDS Policy Law Rev (2007) 0.91
Tracking the microbes in sepsis: advancements in treatment bring challenges for microbial epidemiology. Clin Infect Dis (2007) 0.91
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) on the use of endoscopy simulators for training and assessing skill. Gastrointest Endosc (2012) 0.90